Literature DB >> 12654858

Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model.

Dario Gonzalez1, Arthur O Tzianabos, Caroline A Genco, Frank C Gibson.   

Abstract

The capsular polysaccharide (CPS) of the periodontal pathogen Porphyromonas gingivalis is an important virulence factor for this organism. We purified P. gingivalis CPS, immunized mice with this antigen, and assessed the vaccine potential of P. gingivalis CPS by using the murine oral challenge model. Animals immunized with P. gingivalis CPS developed elevated levels of immunoglobulin M (IgM) and IgG in serum that reacted with whole P. gingivalis organisms. The mice immunized with P. gingivalis CPS were protected from P. gingivalis-elicited oral bone loss. These data demonstrate that P. gingivalis CPS is a vaccine candidate for prevention of P. gingivalis-elicited oral bone loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654858      PMCID: PMC152101          DOI: 10.1128/IAI.71.4.2283-2287.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.

Authors:  A Soininen; I Seppälä; T Nieminen; J Eskola; H Käyhty
Journal:  Vaccine       Date:  1999-04-09       Impact factor: 3.641

2.  Prevalence and distribution of six capsular serotypes of Porphyromonas gingivalis in periodontitis patients.

Authors:  M L Laine; B J Appelmelk; A J van Winkelhoff
Journal:  J Dent Res       Date:  1997-12       Impact factor: 6.116

3.  Capsular polysaccharide-fimbrial protein conjugate vaccine protects against Porphyromonas gingivalis infection in SCID mice reconstituted with human peripheral blood lymphocytes.

Authors:  J I Choi; R E Schifferle; F Yoshimura; B W Kim
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Periodontal diseases in the United States population.

Authors:  R C Oliver; L J Brown; H Löe
Journal:  J Periodontol       Date:  1998-02       Impact factor: 6.993

5.  A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.

Authors:  C A Genco; B M Odusanya; J Potempa; J Mikolajczyk-Pawlinska; J Travis
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 6.  Animal models for Porphyromonas gingivalis-mediated periodontal disease.

Authors:  C A Genco; T Van Dyke; S Amar
Journal:  Trends Microbiol       Date:  1998-11       Impact factor: 17.079

7.  Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice.

Authors:  P J Baker; R T Evans; D C Roopenian
Journal:  Arch Oral Biol       Date:  1994-12       Impact factor: 2.633

8.  Virulence of six capsular serotypes of Porphyromonas gingivalis in a mouse model.

Authors:  M L Laine; A J van Winkelhoff
Journal:  Oral Microbiol Immunol       Date:  1998-10

9.  Microbiota of rapidly progressive periodontitis lesions in association with clinical parameters.

Authors:  J J Kamma; M Nakou; F A Manti
Journal:  J Periodontol       Date:  1994-11       Impact factor: 6.993

10.  Immunization with Porphyromonas gingivalis cysteine protease: effects on experimental gingivitis and ligature-induced periodontitis in Macaca fascicularis.

Authors:  A J Moritz; D Cappelli; M S Lantz; S C Holt; J L Ebersole
Journal:  J Periodontol       Date:  1998-06       Impact factor: 6.993

View more
  19 in total

1.  The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration.

Authors:  Gabriela d'Empaire; Michael T Baer; Frank C Gibson
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

2.  Identification and characterization of the capsular polysaccharide (K-antigen) locus of Porphyromonas gingivalis.

Authors:  Joseph Aduse-Opoku; Jennifer M Slaney; Ahmed Hashim; Alexandra Gallagher; Robert P Gallagher; Minnie Rangarajan; Khalil Boutaga; Marja L Laine; Arie J Van Winkelhoff; Michael A Curtis
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  FOXO1 regulates dendritic cell activity through ICAM-1 and CCR7.

Authors:  Guangyu Dong; Yu Wang; Wenmei Xiao; Sandra Pacios Pujado; Fanxing Xu; Chen Tian; E Xiao; Yongwon Choi; Dana T Graves
Journal:  J Immunol       Date:  2015-03-18       Impact factor: 5.422

4.  Immunoglobulin (Ig)G1 and IgG4 anti-cyclic citrullinated peptide (CCP) associate with shared epitope, whereas IgG2 anti-CCP associates with smoking in patients with recent-onset rheumatoid arthritis (the Swedish TIRA project).

Authors:  K Martinsson; A Johansson; A Kastbom; T Skogh
Journal:  Clin Exp Immunol       Date:  2017-01-10       Impact factor: 4.330

5.  HU protein affects transcription of surface polysaccharide synthesis genes in Porphyromonas gingivalis.

Authors:  Christine Alberti-Segui; Annette Arndt; Carla Cugini; Richa Priyadarshini; Mary E Davey
Journal:  J Bacteriol       Date:  2010-10-01       Impact factor: 3.490

6.  The in vivo T helper type 17 and regulatory T cell immune responses to Aggregatibacter actinomycetemcomitans.

Authors:  S Mahabady; N Tjokro; S Aharonian; H H Zadeh; C Chen; H Allayee; P P Sedghizadeh
Journal:  Mol Oral Microbiol       Date:  2017-06-27       Impact factor: 3.563

7.  Abrogation of neuraminidase reduces biofilm formation, capsule biosynthesis, and virulence of Porphyromonas gingivalis.

Authors:  Chen Li; Bo Hu; Jiang Bian; Jianlan Sun; Weiyan Zhang; Jun Liu; Yaping Pan; Chunhao Li
Journal:  Infect Immun       Date:  2011-10-24       Impact factor: 3.441

8.  HGP44 induces protection against Porphyromonas gingivalis-Induced alveolar bone loss in mice.

Authors:  Kyotaro Muramatsu; Eitoyo Kokubu; Takahiko Shibahara; Katsuji Okuda; Kazuyuki Ishihara
Journal:  Clin Vaccine Immunol       Date:  2011-03-23

9.  Scavenger receptor A is expressed by macrophages in response to Porphyromonas gingivalis, and participates in TNF-alpha expression.

Authors:  M T Baer; N Huang; F C Gibson
Journal:  Oral Microbiol Immunol       Date:  2009-12

10.  Vaccines against periodontitis: a forward-looking review.

Authors:  Jeom-Il Choi; Gregory J Seymour
Journal:  J Periodontal Implant Sci       Date:  2010-08-30       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.